SCHISTOSOMA HAEMATOBIUM
Clinical trials for SCHISTOSOMA HAEMATOBIUM explained in plain language.
Never miss a new study
Get alerted when new SCHISTOSOMA HAEMATOBIUM trials appear
Sign up with your email to follow new studies for SCHISTOSOMA HAEMATOBIUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to keep parasitic infection at bay in kids
Disease control CompletedThis study tested a vaccine called Bilhvax, given alongside a standard treatment (praziquantel), to see if it could delay the return of schistosomiasis (a parasitic infection) in children aged 6 to 9 in Senegal. The vaccine was given as three shots plus a booster one year later. …
Matched conditions: SCHISTOSOMA HAEMATOBIUM
Phase: PHASE3 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New study puts schistosomiasis tests to the test in Near-Elimination zone
Diagnosis CompletedThis completed study in Pemba, Tanzania, compared several diagnostic tests for Schistosoma haematobium, a parasitic worm that causes a debilitating disease. Researchers tested 801 schoolchildren using methods like urine filtration, AI microscopy, and molecular tests. The goal was…
Matched conditions: SCHISTOSOMA HAEMATOBIUM
Sponsor: Stefanie Knopp • Aim: Diagnosis
Last updated Jun 26, 2026 19:19 UTC